Wells Fargo’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-521
Closed -$2K 7674
2021
Q3
$2K Sell
521
-36
-6% -$138 ﹤0.01% 6297
2021
Q2
$3K Sell
557
-179
-24% -$964 ﹤0.01% 6169
2021
Q1
$3K Sell
736
-28,510
-97% -$116K ﹤0.01% 6237
2020
Q4
$127K Sell
29,246
-1,330
-4% -$5.78K ﹤0.01% 5117
2020
Q3
$126K Sell
30,576
-1,333
-4% -$5.49K ﹤0.01% 4982
2020
Q2
$81K Sell
31,909
-17,775
-36% -$45.1K ﹤0.01% 5100
2020
Q1
$144K Sell
49,684
-1,480
-3% -$4.29K ﹤0.01% 4696
2019
Q4
$194K Sell
51,164
-22,090
-30% -$83.8K ﹤0.01% 4808
2019
Q3
$375K Buy
73,254
+50,858
+227% +$260K ﹤0.01% 4441
2019
Q2
$138K Buy
22,396
+13,247
+145% +$81.6K ﹤0.01% 4954
2019
Q1
$65K Sell
9,149
-40,814
-82% -$290K ﹤0.01% 5166
2018
Q4
$428K Buy
49,963
+2,355
+5% +$20.2K ﹤0.01% 4296
2018
Q3
$953K Buy
47,608
+1,385
+3% +$27.7K ﹤0.01% 3937
2018
Q2
$1.19M Buy
46,223
+2,085
+5% +$53.9K ﹤0.01% 3815
2018
Q1
$1.06M Buy
44,138
+3,090
+8% +$73.9K ﹤0.01% 3815
2017
Q4
$1.39M Buy
41,048
+28,061
+216% +$950K ﹤0.01% 3617
2017
Q3
$275K Buy
12,987
+274
+2% +$5.8K ﹤0.01% 4589
2017
Q2
$222K Sell
12,713
-2,453
-16% -$42.8K ﹤0.01% 4563
2017
Q1
$266K Buy
15,166
+3,358
+28% +$58.9K ﹤0.01% 4482
2016
Q4
$200K Sell
11,808
-1,786
-13% -$30.3K ﹤0.01% 4612
2016
Q3
$223K Hold
13,594
﹤0.01% 4263
2016
Q2
$206K Sell
13,594
-354
-3% -$5.36K ﹤0.01% 4257
2016
Q1
$201K Buy
13,948
+8,352
+149% +$120K ﹤0.01% 4272
2015
Q4
$158K Sell
5,596
-15
-0.3% -$424 ﹤0.01% 4446
2015
Q3
$94K Sell
5,611
-23,263
-81% -$390K ﹤0.01% 4753
2015
Q2
$758K Buy
28,874
+26,061
+926% +$684K ﹤0.01% 3755
2015
Q1
$49K Buy
2,813
+2,677
+1,968% +$46.6K ﹤0.01% 4831
2014
Q4
$2K Buy
136
+1
+0.7% +$15 ﹤0.01% 5773
2014
Q3
$3K Sell
135
-73
-35% -$1.62K ﹤0.01% 5734
2014
Q2
$4K Buy
+208
New +$4K ﹤0.01% 5653